cAMP/CREB Signaling and Cardiac Function
cAMP/CREB 信号传导和心脏功能
基本信息
- 批准号:7482978
- 负责人:
- 金额:$ 38.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-01 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdenovirusesAdenylate CyclaseAdrenergic ReceptorAgonistAnimal ModelBindingBinding ProteinsCREB-binding proteinCREB1 geneCardiacCardiac MyocytesCellsCongestiveCongestive Heart FailureCyclic AMPCyclic AMP-Dependent Protein KinasesCyclic AMP-Responsive DNA-Binding ProteinDilated CardiomyopathyDominant-Negative MutationElevationExhibitsGene ExpressionGene TargetingGenesGoalsHeartHeart failureImageKnock-outKnockout MiceLuciferasesMaintenanceMeasuresMediatingModelingModificationMusNuclearPathway interactionsPatientsPerformancePhosphorylationProcessProtein BindingProtein DephosphorylationProtein OverexpressionRNAi vectorRelative (related person)ReporterRoleSecond Messenger SystemsSignal TransductionTestingTranscriptional RegulationTransducersTransgenic MiceTransgenic OrganismsWild Type Mousebeta-adrenergic receptorchromatin immunoprecipitationgain of functionhuman CREBBP proteinimprovedin vivomortalitymutantpolypeptidepromoterprotective effectsecond messengertranscription factor
项目摘要
The second messenger cAMP appears critical for maintenance of cardiac function; intracellular cAMP
accumulation is typically reduced in congestive heart failure (CHF). Increasing cellular cAMP levels in heart
by cardiac-directed expression of adenyl cyclase type VI (ACvi) improves cardiac performance and survival
in animal models of CHF. In contrast, treatment with beta-adrenergic receptor (PAR) agonists increases
mortality in CHF patients. Mechanisms explaining the salutary effects of ACVI are now being addressed, but
little is known about how ACvi expression may influence transcriptional regulation in cardiac myocytes and
other cells in the heart. Cyclic AMP has been shown to stimulate cellular gene expression via the PKA-mediated
phosphorylation of the transcription factor cAMP Response Element Binding protein (CREB) at
Ser133, a modification that promotes recruitment of the coactivator CREB Binding Protein (CBP) to the
promoter. Additionally, cAMP triggers nuclear entry of the latent cytoplasmic CREB coactivator, Transducer
of Regulated CREB 2 (TORC2), which enhances target gene expression via a direct interaction with CREB on
relevant promoters. Supporting a role for CREB in mediating the effects of cAMP on cardiac function,
transgenic mice expressing a phosphorylation defective Ser133Ala CREB polypeptide in heart exhibit dilated
cardiomyopathy. Whether and by what mechanism CREB, CBP, and TORC2 mediate the protective effects
of ACvi on cardiac function, however, is unclear.
The overall goals of this Proposal are:
1. To test whether CREB mediates the salutary effects of ACVI on cardiac function and cardiac myocyte
gene expression.
2. To test the role of the CREB:TORC2 pathway in this process.
第二信使训练营对维持心脏功能至关重要。细胞内营地
充血性心力衰竭(CHF)通常会减少积累。心脏中的细胞营地水平增加
通过心脏定向的腺基环酶VI型(ACVI)的表达可改善心脏性能和生存
在CHF的动物模型中。相反,β-肾上腺素能受体(PAR)激动剂的治疗增加
CHF患者的死亡率。现在已经解决了解释ACVI的有益影响的机制,但是
关于ACVI表达如何影响心肌细胞中的转录调节,几乎了解
心脏中的其他细胞。循环AMP已显示可通过PKA介导的细胞基因表达
转录因子cAMP反应元件结合蛋白(CREB)的磷酸化在
SER133,一种促进共激活因子CREB结合蛋白(CBP)募集的修饰
发起人。此外,营地触发潜在细胞质CREB共激活因子的核进入传感器
调节的CREB 2(TORC2),通过与CREB直接相互作用增强了靶基因表达
相关促进者。支持CREB在介导CAMP对心脏功能的影响中的作用,
表达磷酸化缺陷Ser133ala creb多肽的转基因小鼠表现出扩张
心肌病。无论是什么机构,CREB,CBP和TORC2都会介导保护效果
但是,ACVI在心脏功能上尚不清楚。
该提案的总体目标是:
1。测试CREB是否介导ACVI对心脏功能和心肌细胞的有益影响
基因表达。
2。测试CREB:TORC2途径在此过程中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARC R MONTMINY其他文献
MARC R MONTMINY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARC R MONTMINY', 18)}}的其他基金
Regulation of Hepatic Gluconeogenesis by the CREB:TORC2 Pathway
CREB:TORC2 通路对肝糖异生的调节
- 批准号:
10359198 - 财政年份:2019
- 资助金额:
$ 38.38万 - 项目类别:
Regulation of Hepatic Gluconeogenesis by the CREB:TORC2 Pathway
CREB:TORC2 通路对肝糖异生的调节
- 批准号:
8749897 - 财政年份:2014
- 资助金额:
$ 38.38万 - 项目类别:
Regulation of Hepatic Gluconeogenesis by the CREB:TORC2 Pathway
CREB:TORC2 通路对肝糖异生的调节
- 批准号:
8833274 - 财政年份:2014
- 资助金额:
$ 38.38万 - 项目类别:
Regulation of Hepatic Gluconeogenesis by the CREB:TORC2 Pathway
CREB:TORC2 通路对肝糖异生的调节
- 批准号:
9017999 - 财政年份:2014
- 资助金额:
$ 38.38万 - 项目类别:
Cross-talk between the circadian clock and the cAMP signaling pathway
生物钟和 cAMP 信号通路之间的串扰
- 批准号:
8087954 - 财政年份:2011
- 资助金额:
$ 38.38万 - 项目类别:
Cross-talk between the circadian clock and the cAMP signaling pathway
生物钟和 cAMP 信号通路之间的串扰
- 批准号:
8258301 - 财政年份:2011
- 资助金额:
$ 38.38万 - 项目类别:
Cross-talk between the circadian clock and the cAMP signaling pathway
生物钟和 cAMP 信号通路之间的串扰
- 批准号:
8449748 - 财政年份:2011
- 资助金额:
$ 38.38万 - 项目类别:
Cross-talk between the circadian clock and the cAMP signaling pathway
生物钟和 cAMP 信号通路之间的串扰
- 批准号:
8638961 - 财政年份:2011
- 资助金额:
$ 38.38万 - 项目类别:
REGULATION OF BETA CELL GENES BY GLUCOSE AND INCRETINS
葡萄糖和肠促胰素对 β 细胞基因的调节
- 批准号:
8171328 - 财政年份:2010
- 资助金额:
$ 38.38万 - 项目类别:
相似国自然基金
肝胆肿瘤治疗性溶瘤腺病毒疫苗的研制及其临床前应用性探索
- 批准号:82303776
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PD-1/PD-L1信号促CD21-B细胞BCR髓外二次编辑降低自身反应性在儿童腺病毒肺炎中的作用机制研究
- 批准号:82370015
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于sIgA的V(D)J结构多样性探索腺病毒载体鼻喷新冠奥密克戎疫苗诱导的呼吸道粘膜免疫原性特征
- 批准号:82302607
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
禽腺病毒血清11型反向遗传平台的建立与毒株间致病性差异机制探究
- 批准号:32372997
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CD46和DSG2双受体在人B组腺病毒感染与致病中的协同作用和机制研究
- 批准号:32370155
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
KATP Channels as Downstream targets of adenylyl cyclases during opioid tolerance and withdrawal
KATP 通道作为阿片类药物耐受和戒断期间腺苷酸环化酶的下游靶标
- 批准号:
10451672 - 财政年份:2021
- 资助金额:
$ 38.38万 - 项目类别:
KATP Channels as Downstream targets of adenylyl cyclases during opioid tolerance and withdrawal
KATP 通道作为阿片类药物耐受和戒断期间腺苷酸环化酶的下游靶标
- 批准号:
10317189 - 财政年份:2021
- 资助金额:
$ 38.38万 - 项目类别:
KATP Channels as Downstream targets of adenylyl cyclases during opioid tolerance and withdrawal
KATP 通道作为阿片类药物耐受和戒断期间腺苷酸环化酶的下游靶标
- 批准号:
10618258 - 财政年份:2021
- 资助金额:
$ 38.38万 - 项目类别:
Using a novel model of antidepressant efficacy to discover new compounds and personalized treatments.
使用抗抑郁功效的新模型来发现新化合物和个性化治疗。
- 批准号:
9468094 - 财政年份:2017
- 资助金额:
$ 38.38万 - 项目类别:
Role of XLalphas as a novel alpha-subunit of Gs in hormone signaling
XLalphas 作为 Gs 的新型 α 亚基在激素信号传导中的作用
- 批准号:
8003287 - 财政年份:2010
- 资助金额:
$ 38.38万 - 项目类别: